Point72 Asset Management »

Liminatus Pharma shares owned by Point72 Asset Management

Quarter-by-quarter ownership of Liminatus Pharma (LIMNW) shares owned by Point72 Asset Management from 13F filings

Historical chart of Point72 Asset Management investment in Liminatus Pharma

Tip: Access up to 7 years of quarterly data

All positions including Liminatus Pharma held by Point72 Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Liminatus Pharma by Point72 Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $434 12k 0.04

More positions owned by Point72 Asset Management

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Amazon (AMZN)
Broadcom (AVGO)
Arista Networks Com Shs (ANET)
Microsoft Corporation (MSFT)
Credo Technology Group Holdi Ordinary Shares (CRDO)
Asml Holding N V N Y Registry Shs (ASML)
Spotify Technology S A SHS (SPOT)
Sea Sponsord Ads (SE)
Biogen Idec (BIIB)
Equinix (EQIX)
Coherent Corp (COHR)

View all positions for Point72 Asset Management

Top funds holding Liminatus Pharma

Aristeia Capital
Linden Advisors
Saba Capital Management
Highbridge Capital Management
Moore Capital Management
Polar Securities
MMCAP International Inc. SPC
D. E. Shaw & Co
Millennium Management
Wolverine Asset Management
Blue Owl Capital Holdings
Periscope Capital
Toronto-Dominion Bank
LMR Partners
Gts Securities

View all funds holding Liminatus Pharma